期刊文献+

链球菌噬菌体裂解酶在大肠杆菌中的表达、纯化及活性检测 被引量:3

Expression,purification and characterization of bacteriophage lysin of Streptococcus in Escherichia coli
原文传递
导出
摘要 噬菌体裂解酶是噬菌体产生的细胞壁水解酶,通过水解宿主菌细胞壁使子代噬菌体释放,在体外能高效且特异性地杀死细菌。本研究旨在克隆和表达链球菌噬菌体裂解酶PlyC,并测定其生物学活性。利用PCR方法扩增PlyC的2条肽链PlyCA和PlyCB,构建表达载体pET-32a(+)-PlyCA和pET-32a(+)-PlyCB,分别转化至大肠杆菌BL21(DE3)中,以0.7 mmol/L IPTG在30 oC诱导7 h实现了高效表达,SDS-PAGE分析表明PlyCA和PlyCB表达量均可达菌体总蛋白的30%以上。采用Ni2+-NTA亲和层析法纯化目的蛋白,其纯度大于95%。用透析复性方法得到目的产物重组链球菌噬菌体裂解酶PlyC,以浊度法和平板计数法检测其体外抗菌效果,扫描电子显微镜观察裂解酶作用前后细菌细胞形态变化。结果表明重组PlyC能特异性裂解化脓性链球菌(A组β-溶血性链球菌),以4μg/mL浓度作用于OD600为0.56的菌液60 min后杀菌率达99.6%,扫描电镜观察结果显示该酶作用于菌体后,链球菌细胞裂解,呈碎片状态。本研究为开发一种新型、高效的链球菌感染疾病治疗药物打下了基础。 Lysins are murein hydrolases produced by bacteriophage that act on the cell wall of host bacteria to release progeny phages. Research indicated that lysins could kill bacteria effectively and specifically in vitro. To prepare recombinant bacteriophage lysin of Streptococcus (PlyC) and analyze its biological activity, we obtained two genes of PlyC named PIyCA and PIyCB by PCR amplification and inserted them into pET-32a(+), then transformed the recombinant expression vectors pET-32a(+)-PlyCA and pET-32a(+)-PlyCB into E. coli BL21(DE3) respectively. After induction with 0.7 mmol/L IPTG at 30℃ for 7 h, PlyCA and PlyCB were successfully expressed, SDS-PAGE analysis determined that they all constituted above 30% of the total cell proteins. After Ni^2+ -NTA affinity chromatography, the purity was more than 95%. With the denaturation and protein refolding, we gained the recombinant PlyC. To determine its biological activity, we adopted turbidimetry and plate count method. Before and after lysin treatment, the cell morphology was studied by scanning electron microscopy (SEM). The results showed that the recombinant PlyC could specifically cleavage Streptococcus pyogenes (group A 13-hemolytic streptococci). Under the incubation time of 60 min with 4 μg/mL PlyC in Streptococcus pyogenes dilution which OD600 was 0.56, the germicidal effect was up to 99.6%, while SEM observations showed that cell wall cracked and presented cell debris. This finding laid the foundation for the further study and achieving an effective treatment for streptococcal infection.
出处 《生物工程学报》 CAS CSCD 北大核心 2009年第8期1267-1272,共6页 Chinese Journal of Biotechnology
基金 浙江省科技计划项目(No.2007C33002)资助~~
关键词 噬菌体裂解酶 链球菌 表达 纯化 活性 bacteriophage lysin Streptococcus expression purification activity
  • 相关文献

参考文献16

  • 1Koller T, Nelson D, Nakata M, et al. PlyC, a novel bacteriophage lysin for compartment-dependent proteomics of group A streptococci. Proteomics, 2008, 8(1): 140-148.
  • 2Lopez R, Garcia E, Garcia E Enzymes for anti-infective therapy: phage lysins. Drug Discov Today: Therap Strat, 2004, 1(4): 469-474.
  • 3Schrag S J, Mcgee L, Whitney CG, et al. Emergence of Streptococcus pneumoniae with very-high-level resistance to penicillin. Antimicrob Agents Chemother, 2004, 48(8): 3016-3023.
  • 4Fischetti VA. Bacteriophage lytic enzyme: novel antiinfectives. Trends Microbiol, 2005, 13(10): 491-496.
  • 5Nelson D, Loomis L, Fischetti VA. Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lyric enzyme. Proc Natl Acad Sci USA, 2001, 98(7): 4107-4112.
  • 6Fischetti VA, Vincent, Loomis, et al. Throat lozenge for the treatment of Streptococcus group A: US patent, 7,232,576. 2007-06-19.
  • 7Jacobs MR. Streptococcus pneumoniae: epidemiology and patterns of resistance. Am J Med, 2004, 117(3): 3-15.
  • 8Loeffler JM, Djurkovic S, Fischetti VA. Phage lytic enzyme Cp1-1 as a novel anti-microbial for pneumococcal bacteremia. Infect Immu, 2003, 71(11): 6199-6204.
  • 9Chen CT, Huang C J, Wang YH, et al. Two-step purification of Bacillus circulans chitinase A1 expressed in Escherichia coli periplasm. Protein Expr Purif, 2004, 37(1): 27-31.
  • 10Nelson D, Schuch R, Chahales P, et al. PlyC: A multimeric bacteriophage lysine. Proc Natl Acad Sci USA, 2006, 103(28): 10765-10770.

二级参考文献18

  • 1代丽萍,段广才,范清堂,郗园林,张荣光.幽门螺杆菌融合蛋白HspA-UreB的表达和免疫学活性[J].世界华人消化杂志,2004,12(8):1818-1822. 被引量:3
  • 2陈竞华,王琰,刘群英,王雅明,徐建军,刘华.人源性噬菌体抗体库的构建及HBsAg人单抗的筛选[J].中华微生物学和免疫学杂志,1995,15(3):158-162. 被引量:56
  • 3Sunitha K,Protein Expression Purification,2000年,18卷,338页
  • 4Xie Y,Protein Sci,1996年,5卷,517页
  • 5White C B,J Biol Chem,1995年,270卷,12990页
  • 6Wetlaufer D B,Protein Sci,1995年,4卷,1535页
  • 7Marchetti M, Arico B, Burroni D, et al. Development of a mouse modle of helicobacter pylori infection that mimics human disease [J]. Science, 1995, 267 (5240): 1655-1658.
  • 8黄培堂译 拉塞尔DW著.萨姆布鲁克J,分子克隆实验指南(第3版)[M].北京:科学出版社,2002..
  • 9Fahnert B, Lilie H, Neubauer P. Inclusion bodies: formation and utilization [J]. Adv Biochem Eng Biotechnol, 2004, 89:93-142.
  • 10Raymond Schuch, Daniel Nelson, Vincent A, Fischetti A. Bacteriolytic agent that detects and kills Bacillus anthracis. Nature ,2002,418(8) :884 - 889

共引文献85

同被引文献15

  • 1杨利军,杨涛,解军,张娟,赵志强,罗佳,牛勃.重组Echistatin融合基因工程菌高密度发酵工艺优化[J].中国生物制品学杂志,2006,19(1):84-86. 被引量:4
  • 2K-ller T,Nelson D,Nakata M,et al.PlyC,a novelbacteriophage lysin for compartment-dependentproteomics of group A streptococci. Proteomics . 2008
  • 3SAMBROOK J,FRITSCH EF,MANIATIS T.Molecular Cloning:A Laboratory Manual. . 1989
  • 4Fuchs C,Koster D,Wiebusch S,et al.Scale-up of dialysis fermentation for high cell density cultivation of Escherichia coli. Journal of Biotechnology . 2002
  • 5Lopez R,Garcia E,Garcia P.Enzymes for anti-infectivetherapy:phage lysins. Drug Discov Today:Therap Strat . 2004
  • 6Fischetti VA.Bacteriophage lytic enzyme:novelantiinfectives. Trends in Microbiology . 2005
  • 7Nelson D,Loomis L,Fischetti VA.Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proceedings of the National Academy of Sciences of the United States of America . 2001
  • 8Schrag SJ,Mcgee L,Whitney CG,et al.Emergence ofStreptococcus pneumoniae with very-high-level resistanceto penicillin. Antimicrobial Agents and Chemotherapy . 2004
  • 9Loeffler JM,Djurkovic S,Fischetti VA.Phage Lytic enzyme Cpl1as a Novel Anti-microbial for Pneumcoccal bacteremia. In-fect Immu . 2003
  • 10陈蔚青,陈虹,胡文浪,张建芬.重组人胰岛素样生长因子-Ⅰ工程菌高密度发酵工艺优化[J].中国生化药物杂志,2008,29(2):121-124. 被引量:4

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部